Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Lac-Leamy

Nov 14, 2024 7:30 AM - Nov 15, 2024 4:10 PM

3 Boulevard du Casino, Gatineau, QC J8Y 6X4, Canada

Canada Annual Meeting

The Canada Annual Meeting offers three tracks, Regulatory, Clinical, Safety and Pharmacovigilance!

Session 9 Plenary: AI: Investments and Future Outcomes

Session Chair(s)

Oxana  Iliach, PhD

Oxana Iliach, PhD

Senior Director Regulatory Strategy

Certara, Canada

Marcia  Sam

Marcia Sam

Senior Manager, Regulatory Affairs

Regeneron Canada Company, Canada

This session will provide an overview of Health Canada current view on use of AI and potential future outcomes.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Describe potential use of AI
  • Discuss investments in AI development
  • Explain latest Health Canada expectations for AI outcomes

Speaker(s)

Kelly  Robinson, MSc

Speaker

Kelly Robinson, MSc

Health Canada, Canada

Director General, Marketed Health Products Directorate

Myriam  Salem, MSc

Speaker

Myriam Salem, MSc

Health Canada, Canada

Good Pharmacovigilance Practices National Coordinator

James  Van Loon

Speaker

James Van Loon

Health Canada, Canada

Chief Data Officer, Digital Transformation Branch

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.